Vanderbilt Basic Sciences
-
Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial
A potential schizophrenia treatment discovered through the Warren Center for Neuroscience Drug Discovery has been cleared by the U.S. Food and Drug Administration for use in phase 1 clinical trials—the third WCNDD therapeutic to reach that benchmark. “Vanderbilt is proud that a discovery by our researchers at the Warren Center… Read MoreDec. 4, 2023
-
Researchers discover key step to kidney fibrosis
Researchers at Vanderbilt University Medical Center for the first time have shown that activation of the epidermal growth factor receptor (EGFR) is essential for the development of kidney fibrosis, tissue scarring following injury that can lead to kidney failure. Their discovery, reported Nov. 14 in the journal Nature Communications,… Read MoreNov. 22, 2023
-
Opera meets neuroscience: Vanderbilt’s Lisa Monteggia discusses the science of Nashville Opera’s ‘The Man Who Mistook His Wife for a Hat’
On Nov. 2, Lisa Monteggia, Barlow Family Director of the Vanderbilt Brain Institute and professor of pharmacology, psychiatry and psychology, joined John Hoomes, CEO and artistic director of the Nashville Opera, for a discussion on the artistic approach and scientific research behind the Nashville Opera’s upcoming performance of The Man Who Mistook His Wife for a Hat. Read MoreNov. 9, 2023
-
Kimryn Rathmell wins Doris Duke Foundation Paragon Award
Kimryn Rathmell, MD, PhD, chair of Medicine at Vanderbilt University Medical Center, has received the Paragon Award for Research Excellence from the Doris Duke Foundation (DDF). The award was presented to Rathmell and 24 others who are alumni of the Doris Duke Clinical Scientist Development Awards program during a ceremony… Read MoreNov. 2, 2023
-
Godschalk Research Fund strengthens biomedical innovation
By Aaron Conley Kyle Riedmann Zenobia Godschalk and Mark Godschalk, BA’92, of Atlanta, Georgia, have established the Zenobia and Mark Godschalk Research Fund within the School of Medicine Basic Sciences to support novel research in biology or immunology. The inaugural award of the research fund has been presented to Kyle… Read MoreOct. 27, 2023
-
Vanderbilt-led team receives 2023 Endeavor Award from The Mark Foundation for Cancer Research
A multidisciplinary team of investigators who will probe the connection between obesity and cancer has received a 2023 Endeavor Award from The Mark Foundation for Cancer Research. The three-year, $3 million award will support four closely linked projects exploring the fundamental mechanisms that drive the obesity-cancer connection,… Read MoreOct. 26, 2023
-
Study to explore link between salt taste sensitivity and salt intake, hypertension and genetic variations in individuals of African descent
In collaboration with Sepiso Masenga, MSc, PhD, senior lecturer and researcher at Mulungushi University School of Medicine and Health Sciences in Zambia, Annet Kirabo, DVM, MSc, PhD, associate professor of Medicine at Vanderbilt University Medical Center, has received a new two-year exploratory research grant to study the link between salt… Read MoreOct. 25, 2023
-
Virtual ORCID Workshop for Researchers
The ORCID US Community Consortium, of which Vanderbilt is a member, is offering an ORCID Workshop for Researchers on Nov. 16. As many know, federal agencies and publishers increasingly ask for digital persistent identifiers like ORCID. The VU Libraries recommend this session if you do not already have an account. Virtual ORCID… Read MoreOct. 22, 2023
-
$3M NSF grant to advance biomanufacturing
A team of Vanderbilt engineers, biologists and education specialists have received a $3 million grant from the National Science Foundation to advance large-scale biomanufacturing of cell-derived nanoparticles that can deliver precisely targeted drugs to the site of a disease. The grant is part of the NSF’s Future Manufacturing program that is… Read MoreSep. 28, 2023
-
SOM Enabling Innovation Initiative FAQs
I have a concept or prototype for an invention, biological material, software, or document/content (“matter”) that I think should be legally protected as my intellectual property. What should I know and what should I do? Document the conceptualization and development of your “matter” in writing (as in a lab… Read MoreSep. 22, 2023